English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Uterine sarcomas are unusual pelvic neoplasms, accounting for 5% of cancers of the uterine corpus and their incidence are increasing with the aging of the population. This study aims to assess the pattern of uterine sarcomas diagnosis related to symptons and method for diagnosis, year, age, stage and histological types in the period from 2001 to 2016. There were 123 sarcomas, a higher proportion (~10%) of all uterine corpus neoplasms. The initial signs or symptoms were abnormal uterine bleeding in 77%, and main diagnosis method were uterine curettage (35%) or surgery (34%). A increasing trend of uterine sarcoma with +1.2 cases every 2 years were observed (p<0.05). Diagnosis were done in 62% of women with age >60yo and 56% in advanced stage II-IV. Histology: 47% carcinosarcomas, 22% leiomyosarcomas, 16% endometrial stromal sarcomas (ESS), and 14% adenosarcomas. 76% of carcinosarcomas were diagnosed in age >=60yo and 58% in stage III or IV, while 59% leiomyosarcomas and 50% ESS were registered in <60yo and 56% and 80% in stage I-II, respectively. Conclusion: Uterine sarcomas rates increased in the period 2001-2016, prevailing in age of 60 years or more and 56% at advanced stage, with predominance of carcinosarcomas and leiomyosarcomas.

Uterine sarcomas attended at brazilian referral hospital: a 16-year study